Loading clinical trials...

COMPLETEDPhase 2NCT02072161

Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy

The purpose of this research study is to see how ETC-1002 is tolerated in the body and how ETC-1002 affects the levels of LDL-C (bad cholesterol) in patients receiving ongoing statin therapy.

Lead sponsor: Esperion Therapeutics, Inc.•40 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 3

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

RECRUITINGNA

Pharmacogenomic Informed Statin Prescribing

NCT06568601 · Hypercholesterolemia

RECRUITING

Causes and Natural History of Dyslipidemias

NCT00353782 · Hypercholesterolemia, Atherosclerosis

RECRUITINGPhase 3

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

NCT07037771 · Homozygous Familial Hypercholesterolemia

RECRUITINGPhase 2

A Dose-exploration Study of EDP167 in HoFH

NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 29, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment133

Start dateMar 2014

Last updatedMar 29, 2019

Condition

Hypercholesterolemia

Locations shown

Muscle Shoals, Alabama

Chandler, Arizona

Chino, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 29, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions